X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (399) 399
Publication (102) 102
Newspaper Article (14) 14
Patent (11) 11
Book / eBook (10) 10
Web Resource (9) 9
Book Chapter (7) 7
Book Review (6) 6
Magazine Article (3) 3
Streaming Video (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (204) 204
index medicus (136) 136
oncology (134) 134
female (97) 97
clinical trials (79) 79
middle aged (67) 67
disease-free survival (66) 66
treatment outcome (61) 61
chemotherapy (57) 57
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
cancer (51) 51
adult (50) 50
male (50) 50
aged (46) 46
randomized controlled trials as topic (40) 40
breast neoplasms - drug therapy (38) 38
prognosis (36) 36
breast cancer (35) 35
survival analysis (35) 35
survival (33) 33
therapy (33) 33
chemotherapy, adjuvant (32) 32
statistics & probability (32) 32
validation (31) 31
breast neoplasms - pathology (29) 29
survival rate (29) 29
biomarkers (28) 28
clinical-trials (28) 28
research (28) 28
clinical trials as topic (26) 26
reproducibility of results (25) 25
risk factors (25) 25
colorectal neoplasms - drug therapy (24) 24
medicine, research & experimental (24) 24
analysis (22) 22
meta-analysis (22) 22
proportional hazards models (22) 22
meta-analysis as topic (21) 21
breast neoplasms - genetics (20) 20
care and treatment (20) 20
colorectal cancer (20) 20
fluorouracil (20) 20
mathematical & computational biology (19) 19
antineoplastic agents - therapeutic use (18) 18
fluorouracil - administration & dosage (18) 18
medical research (18) 18
medicine, general & internal (18) 18
neoplasm staging (18) 18
patients (18) 18
research design (18) 18
time factors (18) 18
colorectal neoplasms - mortality (17) 17
end-points (17) 17
follow-up studies (17) 17
pharmacology & pharmacy (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
cancer therapies (16) 16
data interpretation, statistical (16) 16
medical informatics (16) 16
metastasis (16) 16
progression-free survival (16) 16
risk assessment (16) 16
trastuzumab (16) 16
advanced colorectal-cancer (15) 15
bias (15) 15
breast neoplasms - mortality (15) 15
carcinoma (15) 15
disease progression (15) 15
kaplan-meier estimate (15) 15
statistics (15) 15
1st-line treatment (14) 14
colorectal neoplasms - pathology (14) 14
criteria (14) 14
drug administration schedule (14) 14
drug therapy (14) 14
hematology, oncology and palliative medicine (14) 14
medicine (14) 14
neoplasm metastasis (14) 14
statistics as topic (14) 14
tumors (14) 14
cell lung-cancer (13) 13
cyclophosphamide (13) 13
gastroenterology & hepatology (13) 13
leucovorin (13) 13
metaanalysis (13) 13
patient outcomes (13) 13
public, environmental & occupational health (13) 13
randomized-trial (13) 13
surrogate endpoint (13) 13
young adult (13) 13
adjuvant treatment (12) 12
aged, 80 and over (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
docetaxel (12) 12
inflammatory bowel disease (12) 12
open-label (12) 12
oxaliplatin (12) 12
phase-iii (12) 12
randomized clinical-trials (12) 12
surgery (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
2015, Chapman & Hall/CRC biostatistics series, ISBN 1466558156, Volume 72, xvii, 381
Design and Analysis of Clinical Trials for Predictive Medicine provides statistical guidance on conducting clinical trials for predictive medicine. It covers... 
Genetic markers | Genetic Testing | Biological Markers | methods | Clinical trials | Clinical Trials as Topic | Statistical methods | Biochemical markers | Clinical Trials - Pharmaceutical Science | Medical Statistics & Computing | Analysis | Molecular diagnosis | Prognosis
Book
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1125 - 1133
Summary Background Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on... 
Hematology, Oncology and Palliative Medicine | DOUBLE-BLIND | PROGNOSTIC-FACTORS | GENE | ONCOLOGY | EXPRESSION | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vaccinia virus - genetics | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Cancer Vaccines - therapeutic use | Interleukin-2 - immunology | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Risk Assessment | Deoxycytidine - administration & dosage | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Cancer Vaccines - adverse effects | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - immunology | Disease-Free Survival | Interleukin-2 - genetics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Membrane Glycoproteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucin-1 - immunology | Vaccines, Synthetic | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Membrane Glycoproteins - adverse effects | Deoxycytidine - analogs & derivatives | Mucin-1 - genetics | Index Medicus | Interleukin-2 | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Life Sciences | Cancer Vaccines | Membrane Glycoproteins | Antineoplastic Combined Chemotherapy Protocols | Cisplatin | Mucin-1 | Vaccinia virus | Deoxycytidine | Antimetabolites, Antineoplastic | Cancer
Journal Article
2005, Statistics for biology and health, ISBN 9780387202778, xxiii, 408
Both humanitarian and commercial considerations have spurred intensive search for methods to reduce the time and cost required to develop new therapies. The... 
Clinical trials | Medicine: General Issues | Statistics | Statistics for Life Sciences, Medicine, Health Sciences
Book
Journal Article
Clinical Trials, ISSN 1740-7745, 4/2015, Volume 12, Issue 2, pp. 119 - 121
  Hey and Kimmelmans argument against outcome-adaptive randomization reminded me of a review, published a few years ago in this journal, of the concepts of... 
Randomized Controlled Trials as Topic - ethics | Research Design | Humans | Clinical trials | Ethics | Random variables
Journal Article
by Yilmaz, Bahtiyar and Juillerat, Pascal and Øyås, Ove and Ramon, Charlotte and Bravo, Francisco Damian and Franc, Yannick and Fournier, Nicolas and Michetti, Pierre and Mueller, Christoph and Geuking, Markus and Pittet, Valerie E. H and Maillard, Michel H and Rogler, Gerhard and Abdelrahman, Karim and Ademi, Gentiana and Aepli, Patrick and Thomas, Amman and Anderegg, Claudia and Antonino, Anca-Teodora and Archanioti, Eva and Arrigoni, Eviano and Bakker de Jong, Diana and Balsiger, Bruno and Bastürk, Polat and Bauerfeind, Peter and Becocci, Andrea and Belli, Dominique and Bengoa, José M and Biedermann, Luc and Binek, Janek and Blattmann, Mirjam and Boehm, Stephan and Boldanova, Tujana and Borovicka, Jan and Braegger, Christian P and Brand, Stephan and Brügger, Lukas and Brunner, Simon and Bühr, Patrick and Burnand, Bernard and Burk, Sabine and Burri, Emanuel and Buyse, Sophie and Cao, Dahlia-Thao and Carstens, Ove and Criblez, Dominique H and Cunningham, Sophie and D’Angelo, Fabrizia and de Saussure, Philippe and Degen, Lukas and Delarive, Joakim and Doerig, Christopher and Dora, Barbara and Drerup, Susan and Egger, Mara and El-Wafa, Ali and Engelmann, Matthias and Ezri, Jessica and Felley, Christian and Fliegner, Markus and Fournier, Nicolas and Fraga, Montserrat and Franc, Yannick and Frei, Pascal and Frei, Remus and Fried, Michael and Froehlich, Florian and Furlano, Raoul Ivano and Garzoni, Luca and Geyer, Martin and Girard, Laurent and Girardin, Marc and Golay, Delphine and Good, Ignaz and Graf Bigler, Ulrike and Gysi, Beat and Haarer, Johannes and Halama, Marcel and Haldemann, Janine and Heer, Pius and Heimgartner, Benjamin and Helbling, Beat and Hengstler, Peter and Herzog, Denise and Hess, Cyrill and Hessler, Roxane and Heyland, Klaas and Hinterleitner, Thomas and Hirschi, Claudia and Hruz, Petr and Juillerat, Pascal and Khalid-de Bakker, Carolina and Kayser, Stephan and Keller, Céline and Knellwolf (-Grieger), Christina and Knoblauch, Christoph and Köhler, Henrik and Koller, Rebekka and Krieger(-Grübel), Claudia and Künzler, Patrizia and ... and Swiss IBD Cohort Investigators
Nature Medicine, ISSN 1078-8956, 02/2019, Volume 25, Issue 2, pp. 323 - 336
Inflammatory bowel diseases (IBD) can be broadly divided into Crohn’s disease (CD) and ulcerative colitis (UC) from their clinical phenotypes. Over 150 host... 
Phenotypes | Inflammatory bowel diseases | Disease | Medical treatment | Health risks | Antibodies | Tumor necrosis factor-α | Fatty acids | Patients | Refractory materials | Microorganisms | Replicating | Intestine | Disturbances | Remission | Ulcerative colitis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article